首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1336661

全球生物可吸收聚合物市場 - 2023-2030

Global Bioresorbable Polymers Market - 2023-2030

出版日期: 2023年08月22日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

全球生物可吸收聚合物市場將於 2022 年達到 12 億美元，預計到 2030 年將達到 33 億美元，2023-2030 年預測期間年複合成長率為 13.4%。

生物可吸收聚合物市場的顯著成長歸因於汽車、醫療保健和包裝等各個行業的需求不斷成長。它在醫療器械方面具有多種優勢，因此生物可吸收聚合物市場需求增加。生物可吸收市場成長的關鍵因素之一是它提供與人體相容的材料，從而降低感染風險。

亞太地區的生物可吸收聚合物市場成長顯著，中國、日本和印度等國家也出現大幅成長。在不斷成長的醫療保健需求、支持性的監管環境和強大的製造生態系統等因素的推動下，該地區見證了生物可吸收聚合物的巨大成長機會。

例如，2021 年 4 月 21 日，加州大學伯克利分校的科學家發明了一種解決方案，可以在熱和水的幫助下輕鬆分解可堆肥塑膠。這些解決方案適用於其他類型的聚酯塑膠。該解決方案還包括受聚合物保護的酶，但當這些酶暴露於熱和水時，塑膠聚合物會分解成構成成分。

市場動態

生物可吸收聚合物在骨科手術中的進展和應用

由於其獨特的潛在應用，生物可吸收聚合物在醫療領域見證了顯著成長。生物可吸收聚合物在骨科手術中有多種應用，包括骨折固定和骨組織再生。在生物可吸收聚合物的幫助下，它消除了手術和感染的需要。它們暫時固定骨折的骨頭，並在骨頭開始癒合時逐漸分解。

醫療技術領域不斷發展，例如2021年2月1日，3D生物可吸收CMF板上市。由於生物可吸收聚合物具有足夠的強度，它取代了傳統的金屬材料裝置。名為 L-丙交酯和己內酯的生物可吸收聚合物與熔絲系統的組合。例如，2021 年 12 月 8 日，BMF 和 4D 生物材料宣布推出首款 4Degra 生物可吸收材料，該材料可在體內分解。這些材料解決了設計和生物相容性問題。

環境問題和永續包裝需求

由於環境因素的增加和對永續包裝解決方案的需求不斷增加，生物可吸收聚合物見證了包裝行業的最高成長。生物可吸收聚合物也稱為可生物分解聚合物，其中材料自然分解。隨著消費者轉向可生物分解的塑膠，與傳統塑膠相比，這種塑膠造成的污染更少，這是推動包裝行業生物可吸收聚合物成長的關鍵因素之一。

各種合作是減少拋棄式塑膠和促進永續包裝的重要一步，例如，2021 年6 月16 日，Mint 發表新聞稱，DRDO 與Acharya Nagarjuna 大學和Ecolastic 私人有限公司合作推出了一種由植物製成的可生物分解包裝產品，基於食品級和天然材料，是一種天然安全的產品，不會危害環境。該產品的目的是減少拋棄式塑膠的使用。這些塑膠袋具有成本效益、永續且對海洋安全。

生產成本高

高生產成本是生物可吸收聚合物市場的一個主要因素。許多公司發現很難投資生物可吸收聚合物，因為該產品的生產需要很大的製造規模。此外，使用可再生原料會導致更高的成本。生物可吸收聚合物的較高成本阻礙了生物可吸收聚合物在許多行業的成長。

消費者的接受度對於生物可吸收聚合物在市場上的採用起著非常重要的作用。這種生物可吸收聚合物的成長取決於消費者對其應用和優點的了解。在與該市場相關的消費者之間建立信任對其成長至關重要。為了這個市場的成長和知名度，需要具有成本效益的社交媒體、網站和包裝標籤。

COVID-19 影響分析

在 COVID-19 的早期階段，生物可吸收聚合物市場面臨混亂。受疫情影響，許多生產設施暫時關閉和延誤。醫療保健部門正在減少非必要的醫療程序。這影響了對基於生物可吸收聚合物的醫療器械的需求。

COVID-19 大流行措施主要側重於藥物輸送系統。對於疫苗和治療，可以利用生物可吸收聚合物。這增加了對藥物遞送系統（包括微粒、奈米顆粒和支架）的需求。生物可吸收聚合物在組織工程支架中發揮著至關重要的作用，為細胞生長和組織再生提供臨時支持。

俄羅斯-烏克蘭戰爭影響

俄羅斯-烏克蘭戰爭影響生物可吸收聚合物的供應鏈。運輸路線中斷，製造設施受到影響。它導致生產和分銷的延誤。這種衝突造成了經濟和政治不穩定的環境。

俄羅斯和烏克蘭以及與其他捲入戰爭的國家之間的貿易關係受到影響。貿易壁壘、出口限製或進出口法規的變化擾亂了生物可吸收聚合物的流動。這會影響國際貿易，並可能限制製造商和供應商的市場准入。在戰爭期間，醫療保健資源經常被重新分配以解決緊急醫療需求。

Market Overview

The Global Bioresorbable Polymers Market reached US$ 1.2 billion in 2022 and is expected to reach US$ 3.3 billion by 2030 growing with a CAGR of 13.4% during the forecast period 2023-2030.

The significant growth in the bioresorbable polymer market is due to increasing demand from various sectors named as automotive, healthcare and packaging. It offers several advantages in medical appliances due to which the bioresorbable polymer market demand increases. One of the key factors where the bioresorbable market is growing is that it offers materials that are compatible with the human body which reduces the risk of infections.

Asia-Pacific emerged with prominent growth in the bioresorbable polymer market and there is substantial growth in countries like China, Japan and India. The region witnessed significant growth opportunities for bioresorbable polymers, driven by factors such as increasing healthcare demand, a supportive regulatory environment and a robust manufacturing ecosystem.

For instance, on 21 April 2021, scientists from the University of California, Berkeley invented a solution that breaks compostable plastics easily with the help of heat and water. These solutions apply to other types of polyester plastics. This solution also includes enzymes that are protected by polymers but when these enzymes are exposed to heat and water then plastic polymer breaks into constitute components.

Market Dynamics

Advancements and Applications of Bioresorbable Polymers in Orthopedic Surgeries

Bioresorbable polymers witnessed significant growth in the medical field due to their unique potential applications. Bioresorbable polymers found various applications in orthopedic surgeries that include fracture fixations and bone tissue regeneration. With the help of bioresorbable polymer, it eliminates the need for surgery and infections. They temporarily fix the fractured bones and degrade gradually when bones start healing.

The field of medical technology witnessed development, For instance, on 1 Feb 2021, 3D bioresorbable CMF plates were launched. Due to the sufficient strength of the bioresorbable polymer, it replaces traditional devices with metallic materials. Bioresorbable polymers named L-lactide and caprolactone with a combination of fuse filament systems. For instance, on 8 Dec 2021, BMF and 4D biomaterials announce the first 4Degra bioresorbable materials this material degrades in the body. These materials solve design and biocompatibility issues.

Environmental Concerns and Sustainable Packaging Demand

Bioresorbable polymers witnessed the highest growth in the packaging industry due to an increase in environmental factors and increasing demand for sustainable packaging solutions. The bioresorbable polymer also called biodegradable polymer in which materials naturally break down. One of the key factors that drives the growth of bioresorbable polymers in the packaging industry as consumers are moving towards biodegradable plastics which cause less pollution compared to traditional plastics.

A significant step towards reducing single-use plastics and promoting sustainable packaging there is various collaborations, For instance, on 16 Jun 2021, news published in Mint that DRDO collaboration with Acharya Nagarjuna University and Ecolastic private limited launched a biodegradable packaging product made from plant-based food grade and natural materials which is a naturally safe product that doesn't harm the environment. The product has the aim of reducing single-use plastics. These plastic bags are cost-effective, sustainable and ocean-safe.

High Production Cost

High production cost is a major factor for this bioresorbable polymer market. Many companies find it difficult to invest in bioresorbable polymers because the production of this product requires a large manufacturing scale. Additionally, the usage of renewable feedstocks leads to higher costs. The higher cost of bioresorbable polymers hinders the growth of bioresorbable in many industries.

Consumer acceptance plays a very important role in the adoption of bioresorbable polymers in the market. The growth of this bioresorbable polymer depends on consumers' understanding of its applications and benefits. Building trust among consumers related to this market is very crucial for its growth. For the growth and awareness of this market, it requires social media, websites and packaging labels which are cost-effective.

COVID-19 Impact Analysis

In the early stages of COVID-19 bioresorbable polymer market faces disruptions. Due to the pandemic, many manufacturing facilities are temporarily shut down and delayed. The healthcare sector dealing with a decrease in non-essential medical procedures. This impacts the demand for bioresorbable polymer-based medical devices.

COVID-19 pandemic measures focus mainly on drug delivery systems. For vaccines and therapy, bioresorbable polymers can be utilized. This increases the demand for drug delivery systems including microparticles, nanoparticles and scaffolds. Bioresorbable polymers play a crucial role in tissue engineering scaffolds, providing temporary support for cell growth and tissue regeneration.

Russia-Ukraine War Impact

Russia-Ukraine war impacts supply chains of bioresorbable polymers. There are disruptions in transportation routes and manufacturing facilities are affected. It leads to delays in production and distribution. This conflict causes an environment of economic and political instability.

Trade relations between Russia and Ukraine, as well as with other countries involved in the war are affected. Trade barriers, export restrictions, or changes in import and export regulations disrupt the flow of bioresorbable polymers. This impacts international trade and potentially limits market access for manufacturers and suppliers. During the war, healthcare resources are often redirected to address urgent medical needs.

Segment Analysis

The global bioresorbable polymers are segmented based on type, application and region.

Polymer-Based Drug Delivery Systems

There is a significant advancement in the field of drug delivery systems which has made bioresorbable polymers grow in the segment, leading it to cover nearly 35.5% globally. Bioresorbable polymers provide a platform that controls drug delivery systems. This polymer's material is designed to degrade the body over time and eliminates surgical complications. These polymers are biocompatible which means they are well-adaptable by the body and don't release any toxicity.

Scientists growing significant breakthroughs for ocular drug delivery systems, For instance on 18 April 2023, a report by MCDOUGALL Communications in which a scientist from the Center for Ocular Research and Education fabricated a microfluid chip that evaluates the contact lens-based drug release. For better-evaluating drug delivery, scientists designed a soft hydrogel eyes model that includes the upper and lower eyelid. The eyeball and lower eyelid were 3D bio printed which breakthroughs the ocular drug delivery system.

Geographical Penetration

Asia-Pacific Government's Initiatives and Innovations Driving Sustainable Solutions

Asia-Pacific has significant growth in the bioresorbable market and government support has made the region cover more than 58.4% in the forecast period. As growing population plastic pollution also increases in countries named India, China and Singapore government has taken various initiatives to reduce plastic waste.

News by Biospectrum Asia edition, there is a collaboration between Osterpore International and the national university of Singapore startup, For instance, on 11 Dec 2020 named Magloy Tech launched its first fully degradable facial bone fixation solution which consists of magnesium plates and screws. The bioresorbable polymer bone implant dissolves in carbon dioxide and water. This solution leaves zero residues after the wound is cured.

Competitive Landscape

The major global players in the market include: Ashland Global Holdings Inc, Corbion N.V, Evonik Industries AG, Poly-Med Inc, KLS Martin Group, Foster Corporation, Zeus Industrial Products, Seqens Group, REVA Medical, LLC, Nomisma Healthcare Pvt. Ltd.

Why Purchase the Report?

To visualize the global bioresorbable polymers market segmentation based segmented based on type, application and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of bioresorbable polymers market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Application mapping available as excel consisting of key application of all the major players.

The global bioresorbable polymers market report would provide approximately 53 tables, 49 figures and195 Pages

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet By Type
3.2. Snippet By Application
3.3. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Growing Demand for Biocompatible Medical Devices
  - 4.1.1.2. Environmental Concerns and Sustainable Packaging Demand
  - 4.1.1.3. Advancements and Applications of Bioresorbable Polymers in Orthopedic Surgeries
- 4.1.2. Restraints
  - 4.1.2.1. High Production Cost
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 7.1.2. Market Attractiveness Index, By Type
7.2. Polylactic Acid (PLA) *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Polyglycolic Acid (PGA)
7.4. Poly (lactic-co-glycolic acid) (PLGA)
7.5. Polycaprolactone (PCL)
7.6. Others

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Orthopedic Devices*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Drug Delivery
8.4. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.5.1. U.S.
  - 9.2.5.2. Canada
  - 9.2.5.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.5.1. Germany
  - 9.3.5.2. UK
  - 9.3.5.3. France
  - 9.3.5.4. Italy
  - 9.3.5.5. Russia
  - 9.3.5.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.5.1. Brazil
  - 9.4.5.2. Argentina
  - 9.4.5.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.5.1. China
  - 9.5.5.2. India
  - 9.5.5.3. Japan
  - 9.5.5.4. Australia
  - 9.5.5.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis s

11. Company Profiles

11.1. Ashland Global Holdings Inc *
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Corbion N.V
11.3. Evonik Industries AG
11.4. Poly-Med Inc
11.5. KLS Martin Group
11.6. Foster Corporation
11.7. Zeus Industrial Products
11.8. Seqens Group
11.9. REVA Medical, LLC
11.10. Nomisma Healthcare Pvt. Ltd

LIST NOT EXHAUSTIVE